3 stories mentioning HKG:9688Updated 25d ago
Every FINWIRES story that references HKG:9688, newest first.
Zai Lab (HKG:9688) incurred $101.8 million in net loss in the first half of the year, wider by 14% from $89.2 million a year earlier, according to a Wednesday filing to the Hong Kong stock exchange.Loss per share came in at $0.09 compared with $0.08 a year earlier, the biopharmaceutical company said.Net product revenue during the period fell 6% to $201.3 million from $214.7 million a year prior.
Zai Lab (HKG:9688) president and chief operating officer Josh Smiley is being let go by the biopharmaceutical company after three and a half years in the role, according to a Friday statement with the Hong Kong bourse.Zai Lab founder and chief executive Samantha Du will take over Smiley's responsibilities, the firm said.The company stated that the leadership transition is part of an ongoing strategy to streamline operations and enhance performance efficiency.Smiley was previously let go by Eli Lilly over allegations of an inappropriate personal relationship between the then-Lilly CFO and an employee.The biopharmaceutical company's shares slid nearly 2% in Friday morning.
Zai Lab (HKG:9688) reported $51 million in net loss for the first quarter of 2026, widening from a loss of $48.4 million a year earlier, according to a Thursday filing with the Hong Kong bourse.The biopharmaceutical company's shares fell over 6% in morning trade Friday.Loss per share was $0.05, compared with $0.04 in the prior year period.Revenue fell 6% year on year to $99.6 million, figures showed.
